256 related articles for article (PubMed ID: 24556886)
1. Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy.
Ghasemi Falavarjani K; Hashemi M; Modarres M; Hadavand Khani A
Eye (Lond); 2014 May; 28(5):576-80. PubMed ID: 24556886
[TBL] [Abstract][Full Text] [Related]
2. Effect of Serial Intrasilicone Oil Bevacizumab Injections in Eyes With Recurrent Proliferative Vitreoretinopathy Retinal Detachment.
Hsu J; Khan MA; Shieh WS; Chiang A; Maguire JI; Park CH; Garg SJ; Ho AC; Kaiser RS
Am J Ophthalmol; 2016 Jan; 161():65-70.e1-2. PubMed ID: 26432568
[TBL] [Abstract][Full Text] [Related]
3. Intra-silicone Oil Injection of Methotrexate in Retinal Reattachment Surgery for Proliferative Vitreoretinopathy.
Falavarjani KG; Hadavandkhani A; Parvaresh MM; Modarres M; Naseripour M; Alemzadeh SA
Ocul Immunol Inflamm; 2020 Apr; 28(3):513-516. PubMed ID: 31136255
[No Abstract] [Full Text] [Related]
4. Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy.
Ghasemi Falavarjani K; Modarres M; Hadavandkhani A; Karimi Moghaddam A
Eye (Lond); 2015 Sep; 29(9):1199-203. PubMed ID: 26160528
[TBL] [Abstract][Full Text] [Related]
5. Comment on 'Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy'.
Radke NV; Panakanti TK; Radke SN; Ravikoti R
Eye (Lond); 2014 Dec; 28(12):1525. PubMed ID: 25104739
[No Abstract] [Full Text] [Related]
6. Repeated Injection of Methotrexate into Silicone Oil-Filled Eyes for Grade C Proliferative Vitreoretinopathy: A Pilot Study.
Nourinia R; Borna F; Rahimi A; Jabbarpoor Bonyadi MH; Amizadeh Y; Daneshtalab A; Kheiri B; Ahmadieh H
Ophthalmologica; 2019; 242(2):113-117. PubMed ID: 31163427
[TBL] [Abstract][Full Text] [Related]
7. Preservation of anterior capsule during vitrectomy and lensectomy for retinal detachment with proliferative vitreoretinopathy.
MacCumber MW; Packo KH; Civantos JM; Greenberg JB
Ophthalmology; 2002 Feb; 109(2):329-33. PubMed ID: 11825819
[TBL] [Abstract][Full Text] [Related]
8. EFFICACY OF INTRAVITREAL INJECTION OF BEVACIZUMAB IN VITRECTOMY FOR PATIENTS WITH PROLIFERATIVE VITREORETINOPATHY RETINAL DETACHMENT: A Meta-analysis of Prospective Studies.
Zhao XY; Xia S; Wang EQ; Chen YX
Retina; 2018 Mar; 38(3):462-470. PubMed ID: 28272285
[TBL] [Abstract][Full Text] [Related]
9. Inferior retinotomy and silicone oil tamponade for recurrent inferior retinal detachment and grade C PVR in eyes previously treated with pars plana vitrectomy or scleral buckle.
Mancino R; Aiello F; Ciuffoletti E; Di Carlo E; Cerulli A; Nucci C
BMC Ophthalmol; 2015 Dec; 15():173. PubMed ID: 26645589
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of heavy silicone oil tamponade for complicated retinal detachment.
Berker N; Batman C; Ozdamar Y; Eranil S; Aslan O; Zilelioglu O
Eur J Ophthalmol; 2007; 17(5):797-803. PubMed ID: 17932858
[TBL] [Abstract][Full Text] [Related]
11. Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11.
Abrams GW; Azen SP; McCuen BW; Flynn HW; Lai MY; Ryan SJ
Arch Ophthalmol; 1997 Mar; 115(3):335-44. PubMed ID: 9076205
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal Injection of Bevacizumab for the Prevention of Postoperative Proliferative Vitreoretinopathy in High-Risk Patients Selected by Laser Flare Photometry.
Gahon M; Luc A; Zessler A; Pastor G; Angioi-Duprez K; Thilly N; Berrod JP; Conart JB
Ophthalmologica; 2023; 246(5-6):306-313. PubMed ID: 37769629
[TBL] [Abstract][Full Text] [Related]
13. Slow-Release Dexamethasone in Proliferative Vitreoretinopathy: A Prospective, Randomized Controlled Clinical Trial.
Banerjee PJ; Quartilho A; Bunce C; Xing W; Zvobgo TM; Harris N; Charteris DG
Ophthalmology; 2017 Jun; 124(6):757-767. PubMed ID: 28237428
[TBL] [Abstract][Full Text] [Related]
14. TRActional DIabetic reTInal detachment surgery with co-adjuvant intravitreal dexamethasONe implant: the TRADITION STUDY.
Iglicki M; Zur D; Fung A; Gabrielle PH; Lupidi M; Santos R; Busch C; Rehak M; Cebeci Z; Charles M; Masarwa D; Schwarz S; Barak A; Loewenstein A;
Acta Diabetol; 2019 Oct; 56(10):1141-1147. PubMed ID: 31089929
[TBL] [Abstract][Full Text] [Related]
15. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.
Ahmadieh H; Feghhi M; Tabatabaei H; Shoeibi N; Ramezani A; Mohebbi MR
Ophthalmology; 2008 Nov; 115(11):1938-43. PubMed ID: 18584876
[TBL] [Abstract][Full Text] [Related]
16. Outcome of vitrectomy for advanced proliferative vitreoretinopathy complicating primary rhegmatogenous retinal detachment among Nigerians.
Okonkwo ON; Hassan AO; Oderinlo O
Niger J Clin Pract; 2020 Mar; 23(3):337-342. PubMed ID: 32134032
[TBL] [Abstract][Full Text] [Related]
17. Pars plana vitrectomy with and without triamcinolone acetonide assistance in pseudophakic retinal detachment complicated with proliferative vitreoretinopathy.
Acar N; Kapran Z; Altan T; Unver YB; Pasaoglu E
Jpn J Ophthalmol; 2010 Jul; 54(4):331-7. PubMed ID: 20700802
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Ab externo subretinal bands removal during pars plana vitrectomy for rhegmatogenous retinal detachment complicated by proliferative vitreoretinopathy.
Elbaha S; Ghoneem M; Abousamra A; Abouhussein M
BMC Ophthalmol; 2022 May; 22(1):227. PubMed ID: 35596163
[TBL] [Abstract][Full Text] [Related]
19. Prevention and control of proliferative vitreoretinopathy: primary retinal detachment surgery using silicone oil as a planned two-stage procedure in high-risk cases.
Alexander P; Prasad R; Ang A; Poulson AV; Scott JD; Snead MP
Eye (Lond); 2008 Jun; 22(6):815-8. PubMed ID: 17277751
[TBL] [Abstract][Full Text] [Related]
20. Surgical results of heavy silicone oil HWS-45 3000 as internal tamponade for inferior retinal detachment with PVR: a pilot study.
Rizzo S; Romagnoli MC; Genovesi-Ebert F; Belting C
Graefes Arch Clin Exp Ophthalmol; 2011 Mar; 249(3):361-7. PubMed ID: 20842371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
